Aclaris Therapeutics Inc (ACRS) Insider Trading
- $50,845,292.97
- $84,374,175.33
- June 17, 2022
- Kamil Ali-Jackson
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
June 17, 2022 | Director | 19,565 | $15.14 | Sell | $296,214.10 | |
April 25, 2022 | CEO | 20,000 | $15.18 | Sell | $303,600.00 | |
April 21, 2022 | CEO | 25,000 | $15.24 | Sell | $381,000.00 | |
April 18, 2022 | Insider | 30,000 | $16.28 | Sell | $488,400.00 | |
March 11, 2022 | CEO | 56,303 | $15.91 | Sell | $895,780.73 | |
March 10, 2022 | Insider | 27,165 | $15.71 | Sell | $426,762.15 | |
March 10, 2022 | CFO | 12,823 | $15.55 | Sell | $199,397.65 | |
Feb. 9, 2022 | Insider | 383 | $12.68 | Sell | $4,856.44 | |
July 13, 2021 | Insider | 2,631 | $16.98 | Sell | $44,674.38 | |
June 3, 2021 | Insider | 9,492 | $21.96 | Sell | $208,444.32 | |
June 2, 2021 | CEO | 33,260 | $21.64 | Sell | $719,746.40 | |
June 1, 2021 | Insider | 14,000 | $23.01 | Sell | $322,140.00 | |
May 7, 2021 | Insider | 5,416 | $23.52 | Sell | $127,384.32 | |
May 5, 2021 | Insider | 15,000 | $23.98 | Sell | $359,700.00 | |
May 3, 2021 | Insider | 15,000 | $24.59 | Sell | $368,850.00 | |
April 26, 2021 | CFO | 27,339 | $25.80 | Sell | $705,346.20 | |
April 22, 2021 | CFO | 30,000 | $26.84 | Sell | $805,200.00 | |
June 27, 2019 | Major Shareholder | 699,475 | $2.69 | Sell | $1,881,587.75 | |
June 25, 2019 | Major Shareholder | 454,261 | $4.59 | Sell | $2,085,057.99 | |
June 21, 2019 | Major Shareholder | 339,537 | $4.62 | Sell | $1,568,660.94 | |
May 10, 2019 | Major Shareholder | 614,710 | $6.13 | Sell | $3,768,172.30 | |
Oct. 22, 2018 | Director | 372,093 | $10.75 | Buy | $3,999,999.75 | |
Oct. 4, 2018 | Director | 7,100 | $14.00 | Buy | $99,400.00 | |
Aug. 23, 2018 | Director | 6,600 | $15.00 | Buy | $99,000.00 | |
Aug. 15, 2018 | Director | 6,250 | $15.97 | Buy | $99,812.50 | |
June 12, 2018 | Insider | 5,000 | $20.00 | Sell | $100,000.00 | |
May 18, 2018 | Insider | 10,000 | $20.00 | Sell | $200,000.00 | |
May 16, 2018 | Director | 500 | $19.12 | Buy | $9,560.00 | |
May 7, 2018 | CFO | 1,250 | $18.22 | Buy | $22,775.00 | |
April 6, 2018 | Director | 26,700 | $16.54 | Buy | $441,618.00 | |
April 6, 2018 | CFO | 1,250 | $16.59 | Buy | $20,737.50 | |
April 5, 2018 | Insider | 10,000 | $16.75 | Buy | $167,500.00 | |
Aug. 16, 2017 | Director | 108,601 | $23.02 | Buy | $2,499,995.02 | |
March 2, 2017 | Major Shareholder | 425,000 | $30.82 | Sell | $13,098,500.00 | |
Jan. 10, 2017 | Director | 750,000 | $28.25 | Sell | $21,187,500.00 | |
Nov. 18, 2016 | Major Shareholder | 907,828 | $23.03 | Sell | $20,907,278.84 | |
Oct. 26, 2016 | Insider | 3,912 | $21.83 | Sell | $85,398.96 | |
Sept. 28, 2016 | Insider | 1,841 | $24.66 | Sell | $45,399.06 | |
Sept. 16, 2016 | Major Shareholder | 525,550 | $24.19 | Sell | $12,713,054.50 | |
Aug. 26, 2016 | Insider | 3,738 | $20.35 | Sell | $76,068.30 | |
Feb. 23, 2016 | Major Shareholder | 39,726 | $17.15 | Buy | $681,300.90 | |
Jan. 20, 2016 | Major Shareholder | 7,803 | $19.87 | Buy | $155,045.61 | |
Jan. 13, 2016 | Major Shareholder | 15,637 | $19.10 | Buy | $298,666.70 | |
Oct. 29, 2015 | Major Shareholder | 244,200 | $14.00 | Buy | $3,418,800.00 | |
Oct. 22, 2015 | Major Shareholder | 5,410 | $14.03 | Buy | $75,902.30 | |
Oct. 21, 2015 | Major Shareholder | 34,999 | $14.89 | Buy | $521,135.11 | |
Oct. 14, 2015 | Major Shareholder | 42,813 | $14.06 | Buy | $601,950.78 | |
Oct. 13, 2015 | Insider | 335,455 | $11.00 | Buy | $3,690,005.00 | |
Oct. 13, 2015 | Major Shareholder | 409,090 | $11.00 | Buy | $4,499,990.00 | |
Oct. 13, 2015 | Director | 454,545 | $11.00 | Buy | $4,999,995.00 |
Insiders are both buying and selling Aclaris Therapeutics Inc stock.
The insider traders at Aclaris Therapeutics Inc are: Ra Capital Management, Llc, Kamil Ali-Jackson, Frank Ruffo, Neal Walker, Stephen A Tullman, James E Flynn, Joseph Monahan, Anand Mehra, Ventures Fund Vii L.P. Vivo, David N Gordon, Vivo Ventures Vii, Llc, Andrew Kenneth William Powell, Andrew N Schiff, Andrew N. Schiff, Fmr Llc, Sofinnova Venture Partners Vii, and Albert Cha
The most active insider trader at Aclaris Therapeutics Inc is Ra Capital Management, Llc with 9 trades.
Ventures Fund Vii L.P. Vivo has sold the most Aclaris Therapeutics Inc stock with a total value of $47,104,278.84.
Ra Capital Management, Llc has bought the most Aclaris Therapeutics Inc stock with a total value of $30,729,334.10.
The most recent insider trade for Aclaris Therapeutics Inc was on June 17, 2022.
The single biggest insider buy for Aclaris Therapeutics Inc was from Ra Capital Management, Llc with a total value of $24,295,231.80 on Oct. 8, 2015.
The single biggest insider sell for Aclaris Therapeutics Inc was from Anand Mehra with a total value of $21,187,500.00 on Jan. 10, 2017.